An analysis using five years of medical records from tens of thousands of adults diagnosed with obesity and Type 2 diabetes showed "statistically significant increases" of the conditions, the American Academy of Orthopedic Surgeons said in a statement
Overall, tirzepatide and semaglutide share a very similar side effect profile, particularly for digestive issues like nausea, diarrhea, abdominal pain, and dyspepsia
By increasing the number of docking sites for growth hormone on the surface of these cells, BPC-157 helps them multiply faster when growth hormone is present
Liraglutide 3 mg produces mean weight loss of approximately 58 kg (1118 lbs)
Zepbound has FDA approval for two main uses: Chronic weight management in adults with obesity or adults who are overweight with one or more obesity-related health conditions, such as high blood pressure, diabetes, or high cholesterol
An unexpected link between fatty acid synthase and cholesterol synthesis in proinflammatory macrophage activation